Who benefits from orthogeriatric treatment? Results from the Trondheim hip-fracture trial.

ABSTRACT:

Background

Hip fracture patients are heterogenous. Certain patient characteristics are associated with poorer prognosis, but less is known about differences in response to treatment among subgroups. The Trondheim Hip Fracture trial found beneficial effects on mobility and function from comprehensive geriatric care (CGC) compared to traditional orthopaedic care (OC). The aim of this study was to explore differences in response to CGC among subgroups in this trial.

Methods

Secondary analysis of the complete dataset from Trondheim Hip Fracture Trial, a randomised controlled trial including 397 home-dwelling older adults (≥70 years) with a hip fracture. Subgroups were age (over/under 80 years), gender, fracture type (intra-/extracapsular), and pre-fracture instrumental ADL (i-AD

SUBMITTER: Prestmo A 

PROVIDER: S-EPMC4761133 | biostudies-literature | 2016 Feb

REPOSITORIES: biostudies-literature